A new evergreen open-ended global fund investing in Health, Agricultural biotechnology and Industrial biotechnology companies. Unique Fund Structure • Evergreen, open-ended Fund enabling continuous and flexible deal flow • No sunset date or cap on the value of the fund • Geography-agnostic investments • Ongoing capital and strategic support for investments • Management remuneration aligned to investors’ interests • Tax neutral location and tax-effective arrangements at all levels • Bespoke structure for significant investors with long-term horizon Maximise Investment Returns • Robust process for investment selection • Active ongoing involvement with investee companies to manage risk and maximise return • Income flows directly to investors • Flexible reinvestment pathways Investments That Make a Difference • The Fund invests in innovative and disruptive technologies in the biotech space – medical, agricultural, industrial • High growth diversified international later stage investments • Investments that matter to people because they make lives better or improve society as a whole • Measurable impact quantified by internationally accredited organisations • Built through alliances and collaborations with strategic partners, such as pharmaceutical companies, medical research institutes and universities and clinical research and manufacturing organisations First Class Management Team • Experienced team with global networks and track record in commercialisation, licencing, fund development and investment management across Asia, Europe and North America • Managed from Australia, with satellite offices located in strategic geographies